Up to 10% of patients with visceral malignancies develop skin metastases during their clinical course and these metastases constitute about 2% of all skin cancers. Skin metastasis may be the first sign of a clinically silent visceral cancer or represent recurrence of an internal malignancy. In both situations, they are associated with poor prognosis, which can partly be attributed to underdiagnosis. In this paper, a case of relapsing gastric adenocarcinoma, which manifested itself as asymptomatic cutaneous papules and nodules on a patient's head and neck, is reported and histopathological approach to the cutaneous lesions containing signet-ring cell is briefly reviewed.
Introduction
Metastatic skin cancers (MSC) are relatively rare dermatological malignancies. 1 They constitute 2% of all skin tumors and reported incidence rates differ from 0.7% to 9.0%. 1,2 MSC originate most commonly from breast, lung and gastrointestinal tissues, and are recognized as a poor prognostic factor. 2 In this paper, we present a case of relapsing gastric adenocarcinoma with signet-ring cell (SRC) morphology, which presented itself as cutaneous nodular lesions about 4 months after the cessation of chemotherapy.
Case Report
A 57-year-old woman presented with a 2-month history of asymptomatic, steadily growing lesions on her face, neck and shoulders. Her medical history revealed that she was diagnosed with stage IIIa (T 3 N 2 M 0 ) gastric SRC adenocarcinoma (SRCC) 12 months prior in an oncology clinic. At that time, she had underwent total gastrectomy and splenectomy. Her surgical pathology reports revealed cancer-free margins and surgery was followed by adjuvant chemotherapy [infusional folinic acid + 5-Fluorouracil (FUFA)] and radiotherapy directed to the gastric lodge. About four months later after the end of the combined chemotherapy and radiotherapy, the patient had noticed several small lumps on her face and shoulders. Since then, these lesions had been consistently growing. At the time of physical examination, multiple asymptomatic skin lesions consisting of two erythematous papules on her forehead, one solitary nodule on the right preauricular area, another one on her right shoulder and two prominent bright red, fleshy nodules on her neck ranging from 1.0×1.0 to 3.0×4.0 cm (Figure 1a -c) were found. An incisonal biopsy was performed from the papule located on the frontal hairline. Histopa thological sections showed diffuse dermal infiltration of cells with signet-ring morphology. Immunohistochemical staining were negative for HMB45, CD45, ER, PR, GCDFP-15 stains, lowering the possiblity of an melanoma, a metastatic tumor of hematopoietic origin and a metastatic breast cancer, respectively-and positive for AE1/AE3 and mucicarmine indicating a glandular epithelial origin for the SRCs (Figure 2 ). Since the patient was operated in another clinic, original resection material was unavailable to us for a comperative histological and immunohistochemical staining. A working diagnosis for metastatic signet-ring cell carcinoma was made on the basis of the last skin biopsises and patient's medical history, and the patient was referred to the oncology department for further evaluation. Tests performed by the oncology department, including complete blood count, urea and electrolytes, liver function tests, plasma proteins, tumor markers, chest X-ray, breast, abdominal and suprapelvic ultrasound, bilateral mammography, complete abdominal magnetic resonance imaging, bilateral mammography, upper gastrointestinal endoscopy and colonoscopy, revealed no other internal focus, from which the skin lesions could originate. After the completion of the oncological examination and tests, diagnosis of the patient was established as metastatic cutaneous signet-ring cell carcinoma and she was scheduled for a second round of chemotherapy (Figure 1d-f) .
Discussion
Signet-ring pattern defines a specific cell shape change, during which the nucleus of the cell is pushed to the periphery due to the cytoplasmic accumulation of mucin, vacuoles or inclusion bodies, causing the cell to bear a resemblance of a signet-ring. Although SRCs are usually associated with malignancies (i.e., gastric, prostatic, breast cancers, melanoma, etc), 3 and accepted as a poor prognostic factor, they can also be observed in various nonneoplastic conditions (e.g., pseudomembranous colitis, cystic fibrosis, ulcerative colitis), 4 or after formalin fixation as a cytoplasmic shrinkage artifact. 5 In cases without an apparent source for cutaneous SRCs, first step in the differential diagnosis should be to determine whether the cells are neoplastic or not. Wang et al. indicated that even in the setting of a previously diagnosed nonneoplastic disease, benign SRC change can be easily confused with malignant transformation and proposed that lack of the infiltration of lamina propria, rare mitosis and apoptosis and certain histochemical and immunohistochemical staining patterns (positive for E-cadherin and negative for p53 and Ki-67) may be in favor of a nonneoplastic origin for the said SRCs. 4 Other studies about SRC pathogenesis have shown that malign SRCs posses particular qualities, which may be helpful in developing new diagnostic techniques and treatment modalities. Kobayashi et al. found out that highly differentiated colon adenocarcinoma cells were transformed into SRCs, when phosphatidylinositol 3-kinase (PI3K) was activated. 6 They also showed that the activation of PI3K was induced by the activation of ErbB2/ErbB3 complex (a member of cell surface receptor family for epidermal growth factor). 7 At the further steps of the ErbB2/ErbB3 -PI3K cascade, p38 mitogen activated protein kinase (MAPK) is activated, resulting in the loss of intercellular tight junctions. 8 Activation of PI3K is also known to enhance the mucin secretion (Muc4), 9 and transcriptional upregulation of Muc4 is recognized to have antiapopitotic and mitogenic effects in various tumors. 10, 11 PIK3 activation and Muc4 overexpression have also been found in gastric adenocarcinomas, 12, 13 which further supports the role of ErbB2/ErbB3 -PI3K cascade activation in the formation of mucin-laden neoplastic SRCs.
As mentioned above, reported incidence rates of metastatic skin cancers from internal malignancies vary between 0.7-9.0%. 2 A metaanalysis including 22,297 patients with visceral malignancies by Krathen et al.
14 revealed the incidence of skin metastases as 5.3%. According to this study, the most common primary visceral cancers to metastasize to skin were breast cancers (24.0%), renal cancers (4.0%), ovarian cancers (3.8%), bladder cancers (3.6%), lung cancers (3.4%), colorectal cancers (3.4%) and prostate cancers (0.7%) respectively. 14 Gastric cancers, despite being one of the most common cancers in the world, (ranking 5th in worldwide frequency and 3th in the leading causes of cancer relateddeaths), 15 do not develop skin metastases frequently. Most common sites for metastatic spread of the gastric cancers were found to be liver, peritoneoum, lung and bone. 16 Rare skin metastases of gastric cancers are usually observed as umbilical or periumbilical papules or nodules.
2 Signet-ring cell carcinoma (SRCC) is a histologic subtype of gastric cancers which accounts for 8-30% of all stomach cancers and is usually associated with advanced stage cancer and recognized as poor prognostic factor. 14 [ 
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Conclusions
Signet-ring cell may be seen in various neoplastic and nonneoplastic diseases, but these uncommon cells are frequently associated with malignancies and usually develop due to increased intracellular mucin content. When SRCs are found in a skin biopsy, a high level of suspicion for a cancer should be aroused. Since skin metastases can be observed as the first sign of a clinically-silent malignancy, a detailed medical history should be taken and a thorough physical examination must be conducted for a possible tumor. Appropriate tests should be ordered considering the age and sex specific risk factors for the patient. In case of a cancer of unknown primary origin, histological and immunohistological staining methods would be useful to determine the primary tumor. In very rare instances, when the common histological staining methods are inadequate to distinguish a benign signet-ring change from a malign signet-ring cell transformation, observation invasion of lamina propria and a high intracellular PI3K activity may favor a malign cellular transformation. Actually, MAPK and PI3K signaling pathways are now considered as possible therapeutic targets in various cancers and various methods including Western blotting, phospho-flow cytometry and immunofluorescence staining have been proposed for measuring MAPK and PI3K activity. 20 Unfortunately, there isn't yet an established and universally accepted method and the proposed methods require specific laboratory equipment and medical laboratory technicians with certain qualifications, preventing the widespread routine use. For similar reasons, we also could not measure the PI3K activity in our specimen. But, despite these facts, MAPK and PI3K pathways seem to be as promising targets for future diagnostic and therapeutic interventions. 
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